INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Fox Chase Cancer Center
Filadelfia, Estados UnidosPublicaciones en colaboración con investigadores/as de Fox Chase Cancer Center (36)
2023
-
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
British Journal of Cancer, Vol. 128, Núm. 12, pp. 2283-2294
2016
2015
-
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
Clinical Cancer Research, Vol. 21, Núm. 3, pp. 652-657
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477
-
The IASLC/ITMIG thymic epithelial tumors staging project: Proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors
Journal of Thoracic Oncology, Vol. 9, Núm. 9, pp. S65-S72
-
The IASLC/ITMIG thymic epithelial tumors staging project: Proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors
Journal of Thoracic Oncology, Vol. 9, Núm. 9, pp. S81-S87
-
The IASLC/ITMIG thymic epithelial tumors staging project: Proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors
Journal of Thoracic Oncology, Vol. 9, Núm. 9, pp. S73-S80
2012
-
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy
Journal of Clinical Oncology, Vol. 30, Núm. 6, pp. 631-636
2002
-
Elevated JNK activation contributes to the pathogenesis of human brain tumors
Oncogene, Vol. 21, Núm. 33, pp. 5038-5046
-
Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors
American Journal of Pathology, Vol. 160, Núm. 2, pp. 441-447
1999
-
Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells
Cancer Research, Vol. 59, Núm. 19, pp. 4973-4983
1996
-
A Grb2-associated docking protein in EGF- and insulin-receptor signalling
Nature, Vol. 379, Núm. 6565, pp. 560-564
1995
-
Frequent Expression of a Mutant Epidermal Growth Factor Receptor in Multiple Human Tumors
Cancer Research, Vol. 55, Núm. 23, pp. 5536-5539
1994
1993
-
CHROMOSOMAL LOCALIZATION OF THE OX-44 (CD53) LEUKOCYTE ANTIGEN GENE IN MAN AND RODENTS
CYTOGENETICS AND CELL GENETICS, Vol. 64, Núm. 3-4, pp. 217-221
1991
-
MAPPING OF THE OX44 HUMAN-LEUKOCYTE ANTIGEN GENE TO 1P12-P13 BY FLUORESCENCE INSITU HYBRIDIZATION
CYTOGENETICS AND CELL GENETICS
-
The Rat Leukocyte Antigen MRC OX-44 Is a Member of a New Family of Cell Surface Proteins Which Appear to Be Involved in Growth Regulation
Molecular and Cellular Biology, Vol. 11, Núm. 5, pp. 2864-2872
-
Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses
Current Topics in Microbiology and Immunology, Vol. 171, pp. 96-171
1990
-
Activation of multiple genes by provirus integration in the Mlvi-4 locus in T-cell lymphomas induced by Moloney murine leukemia virus
Journal of Virology, Vol. 64, Núm. 5, pp. 2236-2244